BRIEF published on 09/18/2024 at 20:05, 2 months 2 days ago Levée de fonds de 0,25 M€ par Néovacs Investissement Biotechnologie Levée De Fonds Dilution OCEANE-BSA
BRIEF published on 09/18/2024 at 20:05, 2 months 2 days ago Fundraising of €0.25 million by Néovacs Biotechnology Fundraising Investment Dilution OCEANE-BSA
PRESS RELEASE published on 09/18/2024 at 20:00, 2 months 2 days ago Levée de fonds de 0,25 MEUR Néovacs annonce une levée de fonds de 0,25 M€ via l'émission d'OCEANE-BSA pour financer la recherche sur les allergies et investir dans des projets prometteurs en Biotech et MedTech Biotech Levée De Fonds Néovacs OCEANE-BSA Recherche Allergies
BRIEF published on 08/28/2024 at 23:05, 2 months 23 days ago Ajustement de la valeur nominale : Néovacs réduit son capital Euronext Growth Réduction De Capital Santé Financière Valeur Nominale Néovacs
BRIEF published on 08/28/2024 at 23:05, 2 months 23 days ago Adjustment of the nominal value: Neovacs reduces its capital Financial Health Euronext Growth Capital Reduction Nominal Value Néovacs
PRESS RELEASE published on 08/28/2024 at 23:00, 2 months 23 days ago Ajustement de la valeur nominale Néovacs réduit la valeur nominale de son action de 0,005 € à 0,0005 € suite à une réduction de capital. La société biopharmaceutique développe des thérapies pour des maladies inflammatoires et auto-immunes Biopharmaceutique Réduction De Capital Maladies Inflammatoires Valeur Nominale Néovacs
BRIEF published on 07/04/2024 at 20:05, 4 months 16 days ago Résiliation du contrat de financement accordé à Pharnext Financement Biopharmaceutique Pharnext Résiliation Néovacs
BRIEF published on 07/04/2024 at 20:05, 4 months 16 days ago Termination of the financing contract granted to Pharnext Termination Funding Biopharmaceutical Pharnext Néovacs
PRESS RELEASE published on 07/04/2024 at 20:00, 4 months 16 days ago Résiliation du contrat de financement accordé à Pharnext Résiliation du contrat de financement entre Néovacs et Pharnext, suite à des cas de défaut. Le fiduciaire demande le remboursement anticipé de 22 M€. Détails sur les sûretés en place Financement Pharnext Résiliation Néovacs Fiduciaire
BRIEF published on 06/17/2024 at 08:05, 5 months 4 days ago Néovacs collabore avec le CNRS pour développer des formulations lipidiques ARNm Collaboration Scientifique Recherche Biomédicale Formulations Lipidiques ARN Messager Néovacs CNRS
Published on 11/21/2024 at 09:00, 54 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 19 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 29 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 54 minutes ago Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 54 minutes ago Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates
Published on 11/21/2024 at 09:41, 13 minutes ago Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 08:59, 54 minutes ago Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 54 minutes ago Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 39 minutes ago EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 06:58, 2 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 56 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 47 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 34 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
